Company registration number 11849237 (England and Wales)
INSULCON TECHNICAL LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
INSULCON TECHNICAL LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 10
INSULCON TECHNICAL LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
4
349,777
361,762
Tangible assets
5
290,493
328,275
Investments
6
1
-
0
640,271
690,037
Current assets
Stocks
208,920
207,189
Debtors
8
1,957,829
1,116,169
Cash at bank and in hand
223,686
253,591
2,390,435
1,576,949
Creditors: amounts falling due within one year
9
(1,801,768)
(1,009,119)
Net current assets
588,667
567,830
Total assets less current liabilities
1,228,938
1,257,867
Creditors: amounts falling due after more than one year
10
(20,435)
(24,747)
Provisions for liabilities
(28,488)
(32,778)
Net assets
1,180,015
1,200,342
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
1,180,014
1,200,341
Total equity
1,180,015
1,200,342

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 25 September 2025 and are signed on its behalf by:
C Evans
Director
Company Registration No. 11849237
INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

Insulcon Technical Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 24, Orion Way, Orion Business Park, North Shields, Tyne & Wear, England, NE29 7SN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company's immediate parent is Ipcom NV, incorporated in Belgium. The ultimate parent is Green Leaf Topco BV, incorporated in Belgium.

 

The most senior parent entity producing publicly available financial statements is Green Leaf Topco BV. These financial statements are available upon request from Brusselsesteenweg 94 Bus 201 Melle, 9090, Belgium.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

The company meets its day to day working capital requirements through cash generated from operations and related party borrowings, for which a letter of support has been obtained.

 

The company’s forecasts and projections for the next twelve months show that the company should be able to continue in operational existence for that period, taking into account reasonable possible changes in trading performance.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
1.5
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is ten years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.6
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Product development
20% straight line
Software
10% straight line
1.7
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
10% straight line
Fixtures and fittings
10% straight line
Office equipment
20% straight line
Motor vehicles
20% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.8
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.9
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.10
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.11
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
1.12
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.13
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.14
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.15
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.16
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
17,500
15,500
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was: 36 (2023 - 34).

2024
2023
Number
Number
Total
36
34
INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
4
Intangible fixed assets
Goodwill
Product development
Software
Total
£
£
£
£
Cost
At 1 January 2024
428,567
144,727
72,120
645,414
Additions
-
0
4,224
61,650
65,874
At 31 December 2024
428,567
148,951
133,770
711,288
Amortisation and impairment
At 1 January 2024
199,998
67,104
16,550
283,652
Amortisation charged for the year
42,857
23,465
11,537
77,859
At 31 December 2024
242,855
90,569
28,087
361,511
Carrying amount
At 31 December 2024
185,712
58,382
105,683
349,777
At 31 December 2023
228,569
77,623
55,570
361,762
5
Tangible fixed assets
Plant and machinery
Fixtures and fittings
Office equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 January 2024
344,972
72,588
31,971
82,113
531,644
Additions
12,639
7,416
9,679
-
0
29,734
At 31 December 2024
357,611
80,004
41,650
82,113
561,378
Depreciation and impairment
At 1 January 2024
136,418
25,803
10,708
30,440
203,369
Depreciation charged in the year
35,285
9,405
8,509
14,317
67,516
At 31 December 2024
171,703
35,208
19,217
44,757
270,885
Carrying amount
At 31 December 2024
185,908
44,796
22,433
37,356
290,493
At 31 December 2023
208,554
46,785
21,263
51,673
328,275
6
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
1
-
0
INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
6
Fixed asset investments
(Continued)
- 8 -
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 January 2024
-
Additions
21,375,141
Disposals
(11,034,389)
At 31 December 2024
10,340,752
Impairment
At 1 January 2024
-
Impairment losses
10,340,751
At 31 December 2024
10,340,751
Carrying amount
At 31 December 2024
1
At 31 December 2023
-
7
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Refrigeration Spares Limited
31 Harrow Road, Leytonstone, London, England, E11 3PT
Ordinary
100.00
8
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
814,327
861,029
Amounts owed by group undertakings
1,037,633
81,137
Prepayments and accrued income
105,869
174,003
1,957,829
1,116,169
INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
9
Creditors: amounts falling due within one year
2024
2023
£
£
Obligations under finance leases
11
4,313
3,795
Trade creditors
157,601
155,510
Amounts owed to group undertakings
57,316
313,009
Corporation tax
299,010
142,231
Other taxation and social security
227,849
162,975
Dividends payable
827,219
-
0
Other creditors
28,616
18,334
Accruals and deferred income
199,844
213,265
1,801,768
1,009,119
10
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Obligations under finance leases
11
20,435
24,747
11
Finance lease obligations
2024
2023
Future minimum lease payments due under finance leases:
£
£
Within one year
4,313
3,795
In two to five years
20,435
24,747
24,748
28,542

Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

12
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
34,491
28,082

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

Included in the statement of financial position are unpaid pension contributions of £7,882 (2023 - £2,254).

INSULCON TECHNICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
13
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Brian Laidlaw BA CA
Statutory Auditor:
Azets Audit Services
14
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2024
2023
£
£
618,094
117,445
15
Related party transactions

The company undertook related party transactions with wholly owned members of the Ipcom NV group during the period and has taken the exemption from disclosure of these transactions available under FRS 102 section 33.1A.

16
Parent company

The company's immediate parent is Ipcom NV, incorporated in Belguim. The ultimate parent is Green Leaf Topco BV, incorporated in Belguim.

 

The most senior entity producing publicly available financial statements is Green Leaf Topco BV, These financial statements are available upon request from Brusselsesteenweg 94 Bus 201 Melle, 9090, Belgium.

2024-12-312024-01-01falsefalsefalse26 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityC EvansR Boerefijn118492372024-01-012024-12-31118492372024-12-31118492372023-12-3111849237core:Goodwill2024-12-3111849237core:PatentsTrademarksLicencesConcessionsSimilar2024-12-3111849237core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3111849237core:Goodwill2023-12-3111849237core:PatentsTrademarksLicencesConcessionsSimilar2023-12-3111849237core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3111849237core:PlantMachinery2024-12-3111849237core:FurnitureFittings2024-12-3111849237core:ComputerEquipment2024-12-3111849237core:MotorVehicles2024-12-3111849237core:PlantMachinery2023-12-3111849237core:FurnitureFittings2023-12-3111849237core:ComputerEquipment2023-12-3111849237core:MotorVehicles2023-12-3111849237core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3111849237core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3111849237core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3111849237core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3111849237core:CurrentFinancialInstruments2024-12-3111849237core:CurrentFinancialInstruments2023-12-3111849237core:ShareCapital2024-12-3111849237core:ShareCapital2023-12-3111849237core:RetainedEarningsAccumulatedLosses2024-12-3111849237core:RetainedEarningsAccumulatedLosses2023-12-3111849237bus:Director12024-01-012024-12-3111849237core:Goodwill2024-01-012024-12-3111849237core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111849237core:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3111849237core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-3111849237core:PlantMachinery2024-01-012024-12-3111849237core:FurnitureFittings2024-01-012024-12-3111849237core:ComputerEquipment2024-01-012024-12-3111849237core:MotorVehicles2024-01-012024-12-31118492372023-01-012023-12-3111849237core:Goodwill2023-12-3111849237core:PatentsTrademarksLicencesConcessionsSimilar2023-12-3111849237core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-31118492372023-12-3111849237core:Goodwillcore:ExternallyAcquiredIntangibleAssets2024-01-012024-12-3111849237core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssets2024-01-012024-12-3111849237core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:ExternallyAcquiredIntangibleAssets2024-01-012024-12-3111849237core:ExternallyAcquiredIntangibleAssets2024-01-012024-12-3111849237core:PlantMachinery2023-12-3111849237core:FurnitureFittings2023-12-3111849237core:ComputerEquipment2023-12-3111849237core:MotorVehicles2023-12-3111849237core:Subsidiary12024-01-012024-12-3111849237core:Subsidiary112024-01-012024-12-3111849237core:Non-currentFinancialInstruments2024-12-3111849237core:Non-currentFinancialInstruments2023-12-3111849237core:WithinOneYear2024-12-3111849237core:WithinOneYear2023-12-3111849237core:BetweenTwoFiveYears2024-12-3111849237core:BetweenTwoFiveYears2023-12-3111849237bus:PrivateLimitedCompanyLtd2024-01-012024-12-3111849237bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3111849237bus:FRS1022024-01-012024-12-3111849237bus:Audited2024-01-012024-12-3111849237bus:Director22024-01-012024-12-3111849237bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP